Synmosa Biopharma Corporation (TPEX:4114)
Taiwan · Delayed Price · Currency is TWD 32.40
0.00 (0.00%)
Feb 11, 2026, 1:30 PM CST
Synmosa Biopharma Market Cap
Synmosa Biopharma has a market cap or net worth of 16.25 billion as of February 13, 2026. Its market cap has increased by 16.45% in one year.
Market Cap
16.25B
Enterprise Value
18.15B
Revenue
6.11B
Ranking
n/a
PE Ratio
20.52
Stock Price
32.40
Market Cap Chart
Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 16.25B, an increase of 2,684.63%. That is a compound annual growth rate of 18.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 16.25B | - |
| Dec 31, 2025 | 16.25B | 12.06% |
| Dec 31, 2024 | 14.50B | -1.41% |
| Dec 29, 2023 | 14.71B | -8.20% |
| Dec 30, 2022 | 16.02B | 128.36% |
| Dec 30, 2021 | 7.02B | 2.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 29.64B |
| TTY Biopharm Company | 20.91B |
| Grape King Bio | 18.15B |
| Alar Pharmaceuticals | 17.57B |
| ScinoPharm Taiwan | 17.36B |
| YungShin Global Holding | 14.70B |
| Foresee Pharmaceuticals | 13.47B |
| Handa Pharmaceuticals | 12.18B |